PSquared Asset Management’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-168,415
Closed -$12.1M 20
2025
Q4
$12.1M Buy
+168,415
New +$10.9M 5.68% 9

Other funds holding RNAM

PSquared Asset Management's RNAM Position: Q1 2026 in Review

PSquared Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 168,415 shares — an estimated $12.1M sold.

PSquared Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $12.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • PSquared Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • PSquared Asset Management sold 168,415 Avidity Biosciences shares in Q1 2026, an estimated $12.1M.
  • PSquared Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • PSquared Asset Management's Avidity Biosciences position peaked at $12.1M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on PSquared Asset Management's 13F filing for Q1 2026, filed 14 May 2026.